Protection from procedural myocardial injury by atorvastatin is associated with lower levels of adhesion molecules after percutaneous coronary intervention: results from the ARMYDA-CAMs (Atorvastatin for Reduction of MYocardial Damage during Angioplasty-Cell Adhesion Molecules) substudy.

Patti, Giuseppe

Protection from procedural myocardial injury by atorvastatin is associated with lower levels of adhesion molecules after percutaneous coronary intervention: results from the ARMYDA-CAMs (Atorvastatin for Reduction of MYocardial Damage during Angioplasty-Cell Adhesion Molecules) substudy. [electronic resource] - Journal of the American College of Cardiology Oct 2006 - 1560-6 p. digital

Publication Type: Journal Article; Randomized Controlled Trial

1558-3597

10.1016/j.jacc.2006.06.061 doi


Angina Pectoris--blood
Angioplasty, Balloon, Coronary--adverse effects
Atorvastatin
Cardiotonic Agents--therapeutic use
Cell Adhesion Molecules--blood
Coronary Disease--blood
E-Selectin--blood
Heart Injuries--epidemiology
Heptanoic Acids--therapeutic use
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors--therapeutic use
Incidence
Intercellular Adhesion Molecule-1--blood
Multicenter Studies as Topic
Pyrroles--therapeutic use
Vascular Cell Adhesion Molecule-1--blood